Brief: Mineralys Therapeutics Q3 EPS USD -0.52
10/11/2025 21:05
Nov 10 (Reuters) - Mineralys Therapeutics Q3 operating expenses USD 41.131 million. Q3 operating income USD -41.131 million Q3 net income USD -36.932 million
Recent news on Mineralys Therapeutics
See all newsBrief: Mineralys Therapeutics Expands Its Board Of Directors With The Appointments Of Kristine Peterson And Lonnel Coats
Mineralys Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)
U.S. STOCKS ON THE MOVE-Medtronic, Macy's, USA Rare Earth
U.S. STOCKS ON THE MOVE-USA Rare Earth, MiniMed, Rent the Runway